Tracxn Technologies Limited (TRACXN)
Investor Presentation
AI summary
- Q1 FY27 revenue 21.1 Cr, -0.6% YoY, +2.9% QoQ; EBITDA -4.2 Cr, PAT -3.0 Cr
- India revenue 10.6 Cr, +4.4% QoQ, accelerating to 19% annualized growth
- International revenue 10.5 Cr, +1.4% QoQ, QoQ growth turned positive
- Repeatable 3-phase growth playbook: specialized BU teams, product sharpening, sales scale-up
- Sales capacity to nearly double by Dec 2026 to 60 closing reps to boost new customer acquisition
- Launched AI-native data access: MCP connectors, AI assistant, agentic workflows; revenue contribution expected in FY27
- Customer accounts 2,350; deferred revenue 38.8 Cr, +16% YoY
- Employee costs 87% of expenses; no large digital marketing spend
- Global platform with customers in 50+ countries; India and International revenue split 50/50
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 TRACXN — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add TRACXN to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Tracxn Technologies Limited
Important.
The summary above is generated automatically from Tracxn Technologies Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.